Sonoma Pharmaceuticals Inc (SNOA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2026 | 03-2025 | 03-2024 | 03-2023 | 03-2022 | |
| Sales | 19,529 | 14,288 | 12,735 | 13,272 | 12,628 |
| Cost of Goods | 12,114 | 8,823 | 7,990 | 8,795 | 8,635 |
| Gross Profit | 7,415 | 5,465 | 4,745 | 4,477 | 3,993 |
| Operating Expenses | 9,990 | 9,998 | 10,436 | 9,842 | 10,515 |
| Operating Income | -2,461 | -3,710 | -4,701 | -4,570 | -5,887 |
| Other Income | -958 | 803 | -330 | -614 | 469 |
| Pre-tax Income | -3,419 | -2,907 | -5,031 | -5,184 | -5,418 |
| Income Tax | -244 | 550 | -196 | -33 | -332 |
| Net Income Continuous | -3,175 | -3,457 | -4,835 | -5,151 | -5,086 |
| Net Income | $-3,175 | $-3,457 | $-4,835 | $-5,151 | $-5,086 |
| EPS Basic Total Ops | -1.89 | -2.79 | -10.63 | -30.40 | -38.40 |
| EPS Basic Continuous Ops | -1.89 | -2.79 | -10.63 | -30.35 | -38.34 |
| EPS Diluted Total Ops | -1.89 | -2.79 | -10.63 | -30.40 | -38.40 |
| EPS Diluted Continuous Ops | -1.89 | -2.79 | -10.63 | -30.35 | -38.34 |
| EPS Diluted Before Non-Recurring Items | N/A | -2.25 | -7.60 | -21.80 | -38.40 |
| EBITDA(a) | $-2,322 | $-3,572 | $-4,525 | $-4,445 | $-5,701 |